GSK1265744 30mg

DRUG2 trials

Sponsors

ViiV Healthcare

Conditions

HIV InfectionsInfection, Human Immunodeficiency Virus

Phase 1

A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers

CompletedNCT02354950

ViiV HealthcareHIV Infections

Start: 2015-06-22End: 2016-09-16Updated: 2020-08-05

Phase 2

Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)

CompletedNCT00920426

ViiV HealthcareInfection, Human Immunodeficiency Virus

Start: 2009-06-09End: 2009-08-13Updated: 2017-12-06